Search

everythinglearnresearchcommunity

for

Search:↓

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

PRP treatment helps hair growth in most cases, but more research needed.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

A new PAX9 gene mutation causes missing teeth and hair problems, but not skin or nail issues.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Spiny mice are better at regenerating hair after injury than laboratory mice and could help us understand how to improve human skin repair.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.